within Pharmacolibrary.Drugs.ATC.D;

model D02AE01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Carbamide, also known as urea, is an organic compound used mainly in topical dermatological formulations (as urea creams and ointments) for its keratolytic and hydrating properties to treat dry or rough skin conditions such as eczema, psoriasis, or ichthyosis. It is commonly used today and is approved as a non-prescription ingredient in many skin-care products.</p><h4>Pharmacokinetics</h4><p>No specific pharmacokinetic model parameters are published for topical application of carbamide (urea) in humans. Urea is also an endogenous compound important in nitrogen metabolism, and systemic PK parameters are generally not reported in the context of topical therapeutic use.</p><h4>References</h4><ol><li><p>Celleno, L (2018). Topical urea in skincare: A review. <i>Dermatologic therapy</i> 31(6) e12690–None. DOI:<a href=&quot;https://doi.org/10.1111/dth.12690&quot;>10.1111/dth.12690</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30378232/&quot;>https://pubmed.ncbi.nlm.nih.gov/30378232</a></p></li><li><p>Lodén, M (2003). Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. <i>American journal of clinical dermatology</i> 4(11) 771–788. DOI:<a href=&quot;https://doi.org/10.2165/00128071-200304110-00005&quot;>10.2165/00128071-200304110-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14572299/&quot;>https://pubmed.ncbi.nlm.nih.gov/14572299</a></p></li><li><p>Friedman, AJ, et al., &amp; Meckfessel, MH (2016). Urea: A Clinically Oriented Overview from Bench to Bedside. <i>Journal of drugs in dermatology : JDD</i> 15(5) 633–639. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27168272/&quot;>https://pubmed.ncbi.nlm.nih.gov/27168272</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D02AE01;
